Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Correlation between Expression of MVP, Index of p53 and AgNOR Value with Chemoradiotherapy Clinical Response of Cervical Cancer

Atom Indonesia · Vol. 40 No. 3 (2015) · hlm. 135–140

DOI
10.17146/aij.2014.332
ISSN
2356-5322, 0126-1568
Terbit
2015-03-03
Penerbit
National Research and Innovation Agency
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0

Abstrak

Cervical cancer is the most frequent cancer found in Indonesia. The primary treatment of cervical cancer at the locally advanced stage is usually performed by using radiotherapy and chemotherapy. The combination of the two techniques is often called chemoradioherapy. The response to chemoradiotherapy is influenced by biological and physical factors. Major vault protein (MVP) is a ribonucleoprotein which contributes to drug resistance in some cancers. The purposes of this research were: (1) to determine the correlation between the expression of MVP and the index of p53, including AgNOR values and index of MIB-1; and (2) between MVP and chemoradiotherapy clinical response of cervical cancer. Twenty-one microscopic slides taken from biopsy tissues of cervical cancer patients before undergoing treatment were stained to identify MVP, p53, and MIB-1 by means of immunohistochemistry techniques and AgNORs staining. After undergoing chemoradiotherapy treatment, the patients’ clinical responses were observed by pelvic control method. Experimental results showed that there was a correlation between MVP and AgNOR value (P=0.05), but no correlation between MVP and index of p53 (P=0.729), including MIB-1 LI (P=0.63), in untreated cervical cancer. In addition, there was no association between MVP and chemoradioterapy response. In conclusion, MVP expression correlates with the process of cell proliferation before the G2 phase of cell cycle in untreated cancer cells. Those have no association with clinical responses after the completion of treatment.Received: 20 November 2013; Revised: 18 July 2014; Accepted: 28 September 2014

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 268 tautan kepenulisan bersama · 147 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • National Nuclear Energy Agency of Indonesia
  • Dr. Hasan Sadikin General Hospital
  • Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
  • State University of Semarang
  • National Research and Innovation Agency
  • Dharmais Cancer Hospital
  • Hirosaki University
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Teja KisnantoNational Nuclear Energy Agency of Indonesia16
Maringan Diapari Lumban TobingDr. Hasan Sadikin General Hospital12
Yanti LusiyantiNational Nuclear Energy Agency of Indonesia8
Siti NurhayatiNational Nuclear Energy Agency of Indonesia7
Bethy Suryawathy HernowoDr. Hasan Sadikin General Hospital6
Zubaidah AlatasNational Nuclear Energy Agency of Indonesia6
A. AndrionoRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo6
Tur RahardjoNational Nuclear Energy Agency of Indonesia5
Mukh SyaifudinNational Nuclear Energy Agency of Indonesia5
Sofiati PurnamiNational Nuclear Energy Agency of Indonesia4
Dwi RamadhaniNational Nuclear Energy Agency of Indonesia4
Darlina DarlinaNational Nuclear Energy Agency of Indonesia3
Wiwin MailanaNational Nuclear Energy Agency of Indonesia2
Eko PudjadiNational Nuclear Energy Agency of Indonesia2
Ikuo KashiwakuraHirosaki University2
Harry Nugroho Eko SurniyantoroNational Nuclear Energy Agency of Indonesia2
T. IshidaThe University of Tokyo1
Silvia Tri WidyaningtyasUniversity of Indonesia1
I.K.H. BasriNational Nuclear Energy Agency of Indonesia1
Yustinus Ulung AnggraitoState University of Semarang1
Amalia Dyah PratiwiState University of Semarang1
Darlina YusufNational Nuclear Energy Agency of Indonesia1
Nastiti RahajengNational Nuclear Energy Agency of Indonesia1
M. R. A. GaniDharmais Cancer Hospital1
I.K. Hasan BasriNational Research and Innovation Agency1
Ayu Rosemeilia DewiDharmais Cancer Hospital1
V. A. SuvivanNational Research and Innovation Agency1
Masnelli LubisNational Nuclear Energy Agency of Indonesia1
K. D. PurwantiNational Nuclear Energy Agency of Indonesia1
Ryuji OkazakiUniversity of Occupational and Environmental Health Japan1
H. DateHokkaido University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://atomindonesia.brin.go.id/index.php/aij/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Correlation between Expression of MVP, Index of p53 and AgNOR Value with Chemoradiotherapy Clinical Response of Cervical Cancer</dc:title>
	<dc:creator>Kurnia, I.</dc:creator>
	<dc:creator>Siregar, B.</dc:creator>
	<dc:creator>Soetopo, S.</dc:creator>
	<dc:creator>Ramli, I.</dc:creator>
	<dc:creator>Kurjana, T.</dc:creator>
	<dc:creator>Tetriana, D.</dc:creator>
	<dc:creator>Hernowo, B.S.</dc:creator>
	<dc:creator>Andrijono, A.</dc:creator>
	<dc:creator>Tobing, M.D.M.</dc:creator>
	<dc:subject xml:lang="en-US">Major vault protein; p53 MIB-1; AgNOR; Chemoradiotherapy; Cervical cancer</dc:subject>
	<dc:description xml:lang="en-US">Cervical cancer is the most frequent cancer found in Indonesia. The primary treatment of cervical cancer at the locally advanced stage is usually performed by using radiotherapy and chemotherapy. The combination of the two techniques is often called chemoradioherapy. The response to chemoradiotherapy is influenced by biological and physical factors. Major vault protein (MVP) is a ribonucleoprotein which contributes to drug resistance in some cancers. The purposes of this research were: (1) to determine the correlation between the expression of MVP and the index of p53, including AgNOR values and index of MIB-1; and (2) between MVP and chemoradiotherapy clinical response of cervical cancer. Twenty-one microscopic slides taken from biopsy tissues of cervical cancer patients before undergoing treatment were stained to identify MVP, p53, and MIB-1 by means of immunohistochemistry techniques and AgNORs staining. After undergoing chemoradiotherapy treatment, the patients’ clinical responses were observed by pelvic control method. Experimental results showed that there was a correlation between MVP and AgNOR value (P=0.05), but no correlation between MVP and index of p53 (P=0.729), including MIB-1 LI (P=0.63), in untreated cervical cancer. In addition, there was no association between MVP and chemoradioterapy response. In conclusion, MVP expression correlates with the process of cell proliferation before the G2 phase of cell cycle in untreated cancer cells. Those have no association with clinical responses after the completion of treatment.Received: 20 November 2013; Revised: 18 July 2014; Accepted: 28 September 2014</dc:description>
	<dc:publisher xml:lang="en-US">National Research and Innovation Agency</dc:publisher>
	<dc:contributor xml:lang="en-US">National Nuclear Energy Agency</dc:contributor>
	<dc:date>2015-03-03</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://atomindonesia.brin.go.id/index.php/aij/article/view/332</dc:identifier>
	<dc:identifier>10.17146/aij.2014.332</dc:identifier>
	<dc:source xml:lang="en-US">Atom Indonesia; Vol 40, No 3 (2014): December 2014; 135-140</dc:source>
	<dc:source>2356-5322</dc:source>
	<dc:source>0126-1568</dc:source>
	<dc:source>10.17146/aij.2014.%x</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://atomindonesia.brin.go.id/index.php/aij/article/view/332/331</dc:relation>
	<dc:relation>https://atomindonesia.brin.go.id/index.php/aij/article/downloadSuppFile/332/157</dc:relation>
	<dc:relation>https://atomindonesia.brin.go.id/index.php/aij/article/downloadSuppFile/332/158</dc:relation>
	<dc:relation>https://atomindonesia.brin.go.id/index.php/aij/article/downloadSuppFile/332/159</dc:relation>
	<dc:relation>https://atomindonesia.brin.go.id/index.php/aij/article/downloadSuppFile/332/160</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Atom Indonesia</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc-sa/4.0</dc:rights>
</oai_dc:dc>